Cargando…

Bisphosphonates as antimyeloma drugs

In patients with symptomatic multiple myeloma (MM), bisphosphonate (BP) treatment has been widely used to prevent bone loss and preserve skeletal health because of its proven effects on inhibiting osteoclast-mediated bone resorption. In addition to their effects on osteoclasts, it is becoming increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, N D, Lentzsch, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364444/
https://www.ncbi.nlm.nih.gov/pubmed/22005788
http://dx.doi.org/10.1038/leu.2011.282

Ejemplares similares